Bringing the fundamentals into focus…
Back to Edwards Lifesciences Corporation
How Edwards Lifesciences Corporation stacks up
EW · against 60 other Healthcare companies of similar size
Overall
59/ 100
Above the middle of the pack.
Ranked #28 of 61 · scores higher than 55% of peers
Bars: peers in each 10-point band of the overall score19 peers with an overall score of 50–59, including EW · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around EW| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 56.7B USD | 79 | 42 | 96 | 93 | 0 / 2 | |
| 2 | 4.61T JPY (≈$31.3B) | 76 | 93 | 89 | 87 | 1 / 2 | |
| 3 | 534.1B HKD (≈$68.4B) | 75 | 72 | 76 | 96 | 1 / 2 | |
| 3 | 327.3B CNY (≈$45.8B) | 75 | 49 | 64 | 96 | 0 / 2 | |
| 3 | 8.24T JPY (≈$56.0B) | 75 | 57 | 63 | 98 | 0 / 2 | |
| 24 | 45.9B USD | 61 | 84 | — | 78 | 2 / 2 | |
| 25 | 78.1B USD | 60 | 89 | 64 | 59 | 2 / 2 | |
| 25 | 27.5B EUR (≈$30.2B) | 60 | 76 | 78 | 59 | 2 / 2 | |
| 25 | 28.6B USD | 60 | 48 | 54 | 91 | 1 / 2 | |
| 28 | 54.9B USD | 59 | 47 | 40 | 83 | 0 / 2 | |
| 29 | 34.6B USD | 58 | 51 | 68 | 88 | 2 / 2 | |
| 30 | 100.2B USD | 57 | 82 | 54 | 88 | 2 / 2 | |
| 30 | 52.9B USD | 57 | 49 | 58 | 99 | 2 / 2 | |
| 30 | 34.3B USD | 57 | 83 | 42 | 95 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score